gilead (biotechcompany)

literal strings:
  gilead, Gilead, GILEAD
  GILEAD SCIENCES INC, gilead sciences inc, Gilead Sciences Inc, gilead_sciences_inc
  gilead sciences, Gilead Sciences

Help NELL Learn!

NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.

• gilead is a company     
• gilead is a biotech company     
• gilead has acquired pharmasset (biotechcompany)     
• adefovir is a drug worked on by gilead (biotechcompany)     
• truvada is a drug worked on by gilead (biotechcompany)     
• viread is a drug worked on by gilead (biotechcompany)     

categories

• company(100.0%)
• CMC @1103 (100.0%) on 08-mar-2018 [ LAST_WORD=inc 8.41306 SUFFIX=nc 6.77294 LASTSUFFIX=nc 5.31411 LASTPREFIX=in 2.04999 PREFIX=in 1.22934 POS=NN 0.99547 SUFFIX=nces 0.86858 PREFIX=sc -0.99574 SHORT_WORDSHAPE=a -1.51466 CHARS -3.42250 ] using gilead_sciences_inc
• SEAL @611 (50.0%) on 09-jul-2012 [ 1 ] using gilead_sciences_inc
• SEAL @622 (100.0%) on 07-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ] using gilead_sciences
• OE @956 (87.5%) on 20-oct-2015 [ http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/ https://twitter.com/gileadsciences http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/ http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/ http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/ http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/ http://www.google.com/finance?cid=656627 http://www.forbes.com/companies/gilead-sciences/ http://quotes.wsj.com/GILD http://www.barrons.com/quote/stock/us/xnas/gild http://www.bloomberg.com/quote/GILD:US http://www.google.com/finance?cid=656627 http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/ http://www.google.com/finance?cid=656627 http://finance.yahoo.com/q?s=GILD  ] using gilead_sciences
• SEAL @791 (100.0%) on 25-nov-2013 [ 1 ] using gilead
• OE @845 (98.0%) on 07-jun-2014 [ http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/index.html?inline=nyt-org http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/index.html?inline=nyt-org http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/index.html?inline=nyt-org http://topics.nytimes.com/top/news/business/companies/gilead_sciences_inc/index.html?inline=nyt-org http://www.bizjournals.com/profiles/company/us/ca/foster_city/gilead_sciences_inc/18542 http://www.reuters.com/finance/stocks/overview?symbol=GILD.OQ http://www.reuters.com/finance/stocks/overview?symbol=GILD.OQ http://www.bizjournals.com/profiles/company/us/ca/foster_city/gilead_sciences_inc/18542 http://www.bizjournals.com/profiles/company/us/ca/foster_city/gilead_sciences_inc/18542  ] using gilead_sciences_inc
• agent(100.0%)
• Sempasre @1109 (75.0%) on 12-jun-2018 [ "His father 's name was also Gilead ." ] using gilead
• biotechcompany(99.6%)
• CPL @1109 (60.3%) on 12-jun-2018 [ "lower-cost hedged play for _" "company , was acquired by _" "pharmaceutical companies , including _" "pill made by _" "drug is marketed by _" "future cash flows generated by _" "_ distributes this drug" "unrestricted grant from _" "full research report on _" "flows generated by _" "educational grant from _" "drug company called _" "clinical positions at _" "educational grants from _" "biotech companies like _" "clinical trial sponsored by _" "educational grant by _" "unrestricted research grant from _" "speakers bureaus for _" "_ 's DCF analysis" "patent held by _" "inhibitor manufactured by _" "research support from _" "independent educational grants from _" "unrestricted educational grants from _" "speaker honoraria from _" "_ developed the drug" "drug manufacturers like _" "independent educational grant from _" "treatment manufactured by _" "honoraria from _" "_ 's equity research report" "drug was developed by _" "chief scientific officer at _" "clinical research associate at _" "drugs made by _" "drug marketed by _" "grant support from _" "_ is a biopharmaceutical company" "drugs are manufactured by _" "pharmaceutical companies such as _" "drug developed by _" "speakers bureau for _" "pharma major _" "current share price for _" "collaboration agreement with _" "consulting fees from _" "educational grant provided by _" "unrestricted grants from _" "speaker’s bureau for _" "experimental drug from _" "It is manufactured by _" "trial sponsored by _" "unrestricted educational grant by _" "big pharmaceutical companies such as _" "biotechs like _" "hedged play for _" "_ 's DCF Analysis" "exclusive license agreement with _" "It is marketed by _" "_ 's WACC calculation" "_ 's comparative multiple analysis" "unrestricted educational grant from _" "Helpful Information for _" "_ returned the rights" "drugs manufactured by _" "drug made by _" ] using gilead_sciences
• CMC @446 (100.0%) on 01-nov-2011 [ SUFFIX=nc 3.37623 LAST_WORD=inc 3.34397 LASTSUFFIX=nc 3.31886 LASTPREFIX=in 3.31144 PREFIX=in 2.22384 POS=. 1.32096 FULL_WORDSHAPE=a_a_a 0.71072 CHARS -1.63281 WORDS -3.04325 SHORT_WORDSHAPE=a -4.14588 ] using gilead_sciences_inc
• SEAL @213 (99.6%) on 21-feb-2011 [ 1 2 3 4 5 6 7 8 ] using gilead
• SEAL @214 (100.0%) on 22-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 11 ] using gilead_sciences
• CPL @1113 (68.3%) on 02-aug-2018 [ "big losers are _" "Whales playing _" "_ 's Tamiflu" "seasonal patterns for _" "SPX big losers were _" ] using gilead_sciences_inc
• SEAL @287 (99.2%) on 05-jun-2011 [ 1 2 3 4 5 6 7 ] using gilead_sciences_inc

relations

• acquired
• pharmasset (93.8%)
• CPL @1095 (93.8%) on 17-jan-2018 [ "arg1 announced it would purchase arg2" "arg1 bought arg2" "arg1 acquired arg2" "arg1 in its acquisition of arg2" ] using (gilead_sciences, pharmasset)
• agentworkedondrug
• adefovir (100.0%)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (adefovir, gilead)
• truvada (100.0%)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the trade name arg1" "arg2 is the manufacturer of arg1" ] using (truvada, gilead)
• SEAL @221 (100.0%) on 18-mar-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ] using (truvada, gilead_sciences)
• SEAL @263 (100.0%) on 22-may-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ] using (truvada, gilead)
• OE @823 (87.9%) on 17-mar-2014 [   ] using (truvada, gilead_sciences)
• viread (100.0%)
• SEAL @269 (75.0%) on 24-may-2011 [ 1 2 ] using (viread, gilead)
• SEAL @221 (99.6%) on 18-mar-2011 [ 1 2 3 4 5 6 7 8 ] using (viread, gilead_sciences)
• OE @805 (100.0%) on 20-jan-2014 [   ] using (viread, gilead_sciences)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (viread, gilead_sciences)
• vistide (98.4%)
• SEAL @512 (50.0%) on 16-feb-2012 [ 1 ] using (vistide, gilead)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg1 is a registered trademark of arg2" "arg1 are registered trademarks of arg2" ] using (vistide, gilead_sciences)
• SEAL @305 (87.5%) on 19-jun-2011 [ 1 2 3 ] using (vistide, gilead_sciences)
• emtriva (96.9%)
• SEAL @526 (93.8%) on 07-mar-2012 [ 1 2 3 4 ] using (emtriva, gilead_sciences)
• SEAL @523 (50.0%) on 02-mar-2012 [ 1 ] using (emtriva, gilead)
• hepsera (93.8%)
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (hepsera, gilead)
• SEAL @325 (93.8%) on 30-jun-2011 [ 1 2 3 4 ] using (hepsera, gilead_sciences)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 are both manufactured by arg2" ] using (hepsera, gilead)

NELL has only weak evidence for items listed in grey

• acquired
• corus_pharma
• CPL @1097 (87.5%) on 19-jan-2018 [ "arg2 was purchased by arg1" "arg2 was acquired by arg1" "arg2 before its acquisition by arg1" ] using (gilead_sciences, corus_pharma)
• triangle_pharmaceuticals
• CPL @1096 (75.0%) on 18-jan-2018 [ "arg1 acquired arg2" "arg1 recently acquired arg2" ] using (gilead_sciences, triangle_pharmaceuticals)
• nexstar (company)
• CPL @1097 (75.0%) on 19-jan-2018 [ "arg2 merged with arg1" "arg2 was acquired by arg1" ] using (gilead_sciences, nexstar)
• agentworkedondrug
• tamiflu
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 was first developed by arg2" ] using (tamiflu, gilead_sciences)
• createdbyagent
• marilynne_robinson
• SEAL @214 (100.0%) on 22-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ] using (marilynne_robinson, gilead)
• acquired
• triangle (arthropod)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (book)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (geometricshape)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (male)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (monument)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (museum)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (musicalbum)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (musicinstrument)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (scientificterm)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (sport)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (sportsequipment)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• triangle (street)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• nexstar (tableitem)
• CPL @1097 (75.0%) on 19-jan-2018 [ "arg2 merged with arg1" "arg2 was acquired by arg1" ] using (gilead_sciences, nexstar)
• triangle (weapon)
• CPL @1099 (75.0%) on 23-jan-2018 [ "arg2 was acquired by arg1" "arg2 is now owned by arg1" ] using (gilead_sciences, triangle)
• cityhasstreet
• route
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 DD South into arg2" ] using (route, gilead)
• personhasfather
• lt__joseph_r__hunt
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 dwelt from arg2" ] using (joseph, gilead)
• abraham
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 dwelt from arg2" ] using (abraham, gilead)
• isaac
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 dwelt from arg2" ] using (isaac, gilead)
• jacob
• CPL @1103 (75.0%) on 06-mar-2018 [ "arg1 awaked out of arg2" "arg1 awaked out from arg2" ] using (jacob, gilead)